KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates and ready-to-use formulations REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS DRUG DELIVERY DEVICES SYRINGES & NEEDLES DIAGNOSTICS CATHETERS Clarifying PP Sorbitol-free for transparent applications with reduced migration and improved thermal stability     Lubricant— permanent/ non-migrating Fast acting reduction in friction for wide variety of polymers such as PP, ABS, POM, PC    Protection from UV in transparent applications for PP, PE, PETG, COP UV blocking in 290-450nm with no impact on clarity; can be combined with colors (e.g., amber)   Antistatic ready-to- use solution for PP, ABS, PC/ABS Permanent/non-migrating; fast decay time independent of % relative humidity  Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP; reduction in yellowing using Color Compensation Technology (CCT)    Reduced material consumption/cycle time—nucleation Fast acting new generation nucleant for PE and PP; improved thermal and mechanical properties allows wall thinning; reduction of tolerance/dimensional problems between different colors    Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser for PE,PP, ABS, PC, POM     Antioxidants for PE, PP, TPE Thermal protection during converting/downstream sterilization    Brand protection/ anticounterfeit Covert and non-covert systems   Healthcare use limitations apply—see below. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates or formulations REGULATORY SUPPORT • Pre-tested raw materials: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS EBM/IBM CONTAINERS CLOSURES FILM COMBINATION DEVICES Clarifying PP Sorbitol-free—possibilities in packaging ocular solutions    Slip/torque reduction Slip for PE, PP films, processing aid, torque reduction for closures   Protection from UV in transparent packaging for PP, PE, PETG, COP UV blocking in 290–450nm with no impact on clarity    Antistatic ready-to-use solution for PE films e.g. Reduction in yellowing using Color Compensation Technology (CCT)   Reduced material consumption/cycle time/improved properties—nucleation Fast acting new generation nucleant for PE and PP; improved dimensional stability, thermal and mechanical properties    Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser    Antiblock for PE/PP film Non-migrating additive system maintaining high gloss and printability  Antioxidants for PE, PP, TPE Thermal protection during converting/ downstream sterilization     Brand protection/ anticounterfeit Range of covert and non-covert systems    Volatiles/odor absorber for PE/PP Physical absorption of a wide range of molecules responsible for odor, VOC and potential extractables/ leachables in plastics   Healthcare use limitations apply—see below. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

It yields precise markings without the use of solvents or inks, or the need of any pre-treatment, making it a more environmentally friendly process. KEY CHARACTERISTICS • Designed for Nd:YAG lasers operating between 1060-1070 nm • Available for different polymers including PP, PE, PC, PBT, POM, ABS, MABS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Can be designed for dark marking on natural or white/light colored background or light marking on black/dark background REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.

Three Months Ended June 30, 2022 Three Months Ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income attributable to Avient shareholders $ 84.7 $ 0.92 $ 68.8 $ 0.74 Special items, after tax (Attachment 3) 5.1 0.06 11.7 0.13 Adjusted net income / EPS - excluding special items $ 89.8 $ 0.98 $ 80.5 $ 0.87 Six months ended June 30, 2022 Six months ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income attributable to Avient shareholders $ 168.9 $ 1.83 $ 148.1 $ 1.60 Special items, after tax (Attachment 3) 12.3 0.13 14.3 0.16 Adjusted net income / EPS - excluding special items $ 181.2 $ 1.96 $ 162.4 $ 1.76 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Sales $ 1,302.4 $ 1,235.2 $ 2,596.2 $ 2,397.5 Cost of sales 998.6 946.5 1,998.7 1,806.4 Gross margin 303.8 288.7 597.5 591.1 Selling and administrative expense 174.3 180.6 339.4 362.6 Operating income 129.5 108.1 258.1 228.5 Interest expense, net (16.2) (19.5) (33.1) (38.8) Other income, net 1.4 1.2 0.8 2.7 Income before income taxes 114.7 89.8 225.8 192.4 Income tax expense (30.0) (20.4) (56.6) (43.3) Net income 84.7 69.4 169.2 149.1 Net income attributable to noncontrolling interests — (0.6) (0.3) (1.0) Net income attributable to Avient shareholders $ 84.7 $ 68.8 $ 168.9 $ 148.1 Earnings per share attributable to Avient common shareholders - Basic $ 0.93 $ 0.75 $ 1.85 $ 1.62 Earnings per share attributable to Avient common shareholders - Diluted $ 0.92 $ 0.74 $ 1.83 $ 1.60 Cash dividends declared per share of common stock $ 0.2375 $ 0.2125 $ 0.4750 $ 0.4250 Weighted-average shares used to compute earnings per common share: Basic 91.4 91.3 91.4 91.3 Diluted 92.1 92.4 92.2 92.3 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation and amortization $ (2.6) $ (1.5) $ (7.0) $ (3.3) Environmental remediation costs (3.0) (12.5) (5.0) (13.0) Reimbursement of previously incurred environmental costs 7.6 — 8.2 4.5 Acquisition related costs — 1.4 — 1.4 Impact on cost of sales 2.0 (12.6) (3.8) (10.4) Selling and administrative expense: Restructuring, legal and other (4.2) (0.4) (3.3) (1.7) Acquisition related costs (2.1) (1.2) (5.0) (4.5) Impact on selling and administrative expense (6.3) (1.6) (8.3) (6.2) Impact on operating income (4.3) (14.2) (12.1) (16.6) Other income, net — — 0.1 — Mark-to-market on cross-currency swaps 0.9 — 0.9 — Impact on income before income taxes (3.4) (14.2) (11.1) (16.6) Income tax benefit on above special items 0.8 3.4 2.8 4.3 Tax adjustments(2) (2.5) (0.9) (4.0) (2.0) Impact of special items on net income attributable to Avient Shareholders $ (5.1) $ (11.7) $ (12.3) $ (14.3) Diluted earnings per common share impact $ (0.06) $ (0.13) $ (0.13) $ (0.16) Weighted average shares used to compute adjusted earnings per share: Diluted 92.1 92.4 92.2 92.3 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Sales: Color, Additives and Inks $ 649.1 $ 624.4 $ 1,298.6 $ 1,233.7 Specialty Engineered Materials 243.9 240.6 488.6 457.1 Distribution 443.2 404.4 876.1 767.1 Corporate and eliminations (33.8) (34.2) (67.1) (60.4) Sales $ 1,302.4 $ 1,235.2 $ 2,596.2 $ 2,397.5 Gross margin: Color, Additives and Inks $ 193.4 $ 193.4 $ 385.5 $ 390.9 Specialty Engineered Materials 67.4 69.6 137.2 134.3 Distribution 42.9 40.1 82.2 79.4 Corporate and eliminations 0.1 (14.4) (7.4) (13.5) Gross margin $ 303.8 $ 288.7 $ 597.5 $ 591.1 Selling and administrative expense: Color, Additives and Inks $ 99.8 $ 107.1 $ 197.4 $ 215.8 Specialty Engineered Materials 30.8 32.3 60.9 62.8 Distribution 15.8 16.4 30.9 31.7 Corporate and eliminations 27.9 24.8 50.2 52.3 Selling and administrative expense $ 174.3 $ 180.6 $ 339.4 $ 362.6 Operating income: Color, Additives and Inks $ 93.6 $ 86.3 $ 188.1 $ 175.1 Specialty Engineered Materials 36.6 37.3 76.3 71.5 Distribution 27.1 23.7 51.3 47.7 Corporate and eliminations (27.8) (39.2) (57.6) (65.8) Operating income $ 129.5 $ 108.1 $ 258.1 $ 228.5 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 119.5 $ 111.6 $ 240.0 $ 227.7 Specialty Engineered Materials 44.3 45.4 91.8 87.4 Distribution 27.3 23.9 51.7 48.1 Corporate and eliminations (25.1) (39.0) (51.1) (63.8) Other income, net 1.4 1.2 0.8 2.7 EBITDA $ 167.4 $ 143.1 $ 333.2 $ 302.1 12 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. Three Months Ended June 30, 2022 2021 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results Income from before income taxes $114.7 $ 3.4 $ 118.1 $ 89.8 $ 14.2 $ 104.0 Income tax expense - GAAP (30.0) — (30.0) (20.4) — (20.4) Income tax impact of special items (Attachment 3) — (0.8) (0.8) — (3.4) (3.4) Tax adjustments (Attachment 3) — 2.5 2.5 — 0.9 0.9 Income tax (expense) benefit $ (30.0) $ 1.7 $ (28.3) $ (20.4) $ (2.5) $ (22.9) Effective Tax Rate(1) 26.1 % 23.9 % 22.7 % 22.0 % (1) Rates may not recalculate from figures presented herein due to rounding 13 Six Months Ended June 30, 2022 2021 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results Income from before income taxes $225.8 $ 11.1 $ 236.9 $192.4 $ 16.6 $ 209.0 Income tax expense - GAAP (56.6) — (56.6) (43.3) — (43.3) Income tax impact of special items (Attachment 3) — (2.8) (2.8) — (4.3) (4.3) Tax adjustments (Attachment 3) — 4.0 4.0 — 2.0 2.0 Income tax (expense) benefit $ (56.6) $ 1.2 $ (55.4) $ (43.3) $ (2.3) $ (45.6) Effective Tax Rate(1) 25.0 % 23.4 % 22.5 % 21.8 % (1) Rates may not recalculate from figures presented herein due to rounding Reconciliation of EBITDA by Segment Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Operating income: Color, Additives and Inks $ 93.6 $ 86.3 $ 188.1 $ 175.1 Specialty Engineered Materials 36.6 37.3 76.3 71.5 Distribution 27.1 23.7 51.3 47.7 Corporate and eliminations (27.8) (39.2) (57.6) (65.8) Operating income $ 129.5 $ 108.1 $ 258.1 $ 228.5 Items below OI in Corporate: Other income, net $ 1.4 $ 1.2 $ 0.8 $ 2.7 Depreciation & amortization: Color, Additives and Inks $ 25.9 $ 25.3 $ 51.9 $ 52.6 Specialty Engineered Materials 7.7 8.1 15.5 15.9 Distribution 0.2 0.2 0.4 0.4 Corporate and eliminations 2.7 0.2 6.5 2.0 Depreciation & Amortization $ 36.5 $ 33.8 $ 74.3 $ 70.9 EBITDA: Color, Additives and Inks $ 119.5 $ 111.6 $ 240.0 $ 227.7 Specialty Engineered Materials 44.3 45.4 91.8 87.4 Distribution 27.3 23.9 51.7 48.1 Corporate and eliminations (25.1) (39.0) (51.1) (63.8) Other income, net 1.4 1.2 $ 0.8 $ 2.7 EBITDA $ 167.4 $ 143.1 $ 333.2 $ 302.1 14 Three Months Ended June 30, Six Months Ended June 30, Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 2022 2021 Net income – GAAP $ 84.7 $ 69.4 $ 169.2 $ 149.1 Income tax expense 30.0 20.4 56.6 43.3 Interest expense 16.2 19.5 33.1 38.8 Depreciation and amortization 36.5 33.8 74.3 70.9 EBITDA $ 167.4 $ 143.1 $ 333.2 $ 302.1 Special items, before tax 3.4 14.2 11.1 16.6 Depreciation and amortization included in special items (1.1) 1.4 (3.2) 0.8 Adjusted EBITDA $ 169.7 $ 158.7 $ 341.1 $ 319.5 Three Months Ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of $ EPS Net income attributable to Avient shareholders $ 68.8 $ 0.74 Special items, after tax (Attachment 3) 11.7 0.13 Adjusted net income / EPS - excluding special items 80.5 0.87 FX adjustment (4.9) (0.05) Adjusted net income / EPS - excluding special items, adjusted for FX $ 75.6 $ 0.82 NEWS RELEASE Attachment 1

Tax services include tax compliance, tax advice and tax planning. Crist Senior Vice President, President of Color, Additives and Inks (“CAI”) Michael A. Van Hulle, Former Senior Vice President, President of Color, Additives and Inks Michael A.

Around the world, in our more than 100 locations, Avient is committed to regulatory and legal compliance. This section contains the regulatory, compliance, disclosure and disclaimer information you need. Avient ensures compliance with applicable regulatory requirements and industry standards and acts

Cash dividends declared per share of common stock    Color, Additives and Inks    Color, Additives and Inks

Cash dividends declared per share of common stock Color, Additives and Inks Color, Additives and Inks

Cash dividends declared per share of common stock Color, Additives and Inks Color, Additives and Inks

Cash dividends declared per share of common stock Color, Additives and Inks Color, Additives and Inks